January 2019 FDA Recall Drug by Us Compounding Inc
D-0482-2019 - Labeling

This Class II drug recall was voluntarily initiated by Us Compounding Inc on January 24, 2019 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0482-2019

Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.
Initiated
01-24-2019
Reported
02-20-2019
Quantity
1931 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA.
LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US Compounding, 1270 Don's Lane, Conway, AR, 800-718-3588, Barcode 62295501303.

Batch or Lot Expiration Information

Lot# Labeled as
Lot# YYYDDYY@XX, Beyond Use Date: MM/DD/YYYY.